Indoco Remedies Limited Moxifloxacin Export Data — India (DGFT 2022–2026)

Name: Indoco Remedies Limited Moxifloxacin Export Records India — #14 Exporter, 18 Shipments, $239.8K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Moxifloxacin

India Pharmaceutical Trade Intelligence

$32.8M336 Suppliers137 CountriesHS 30049099

ExportsIndia → NIGERIA44.8%India → UNITED STATES17.5%

ImportsUNITED STATES → India$160.3B BRAZIL → India$30.7B

#1 Buyer: NATIONAL TUBERCULOSIS

Indoco Remedies Limited — Moxifloxacin Exporter #14 | $239.8K Trade Value | TransData Nexus | TransData Nexus

Indoco Remedies Limited — Moxifloxacin Exporter Profile

Indian Pharmaceutical Exporter · #14 for Moxifloxacin · $239.8K export value · DGFT Verified

Indoco Remedies Limited is the #14 Indian exporter of Moxifloxacin with $239.8K in export value and 18 verified shipments. Indoco Remedies Limited holds a 0.7% market share in Moxifloxacin exports across 8 countries. The company exports 13 pharmaceutical products worth $73.5M across 9 therapeutic categories.

Indoco Remedies Limited — Moxifloxacin Export Profile: Buyers & Destinations

Indoco Remedies Limited Moxifloxacin export treemap — buyers and destination countries | TransData Nexus

Where Does Indoco Remedies Limited Export Moxifloxacin?

Country	Value	Shipments	Share
FRANCE	$191.3K	9	79.8%
TRINIDAD AND TOBAGO	$17.5K	1	7.3%
SOUTH AFRICA	$17.5K	1	7.3%
BENIN	$4.6K	1	1.9%
CONGO	$4.3K	3

Who Are the Top Buyers of Moxifloxacin from Indoco Remedies Limited?

Buyer	Country	Value	Orders
TO THE ORDER	FRANCE	$21.5K	2

Indoco Remedies Limited supplies Moxifloxacin to 1 buyers globally. The largest buyer is TO THE ORDER (FRANCE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Moxifloxacin Formulations Does Indoco Remedies Limited Export?

Product Description / Formulation	Value	Shipments
MOFLOREN OPHTHALMIC SOLUTION 5ML, PACK OF - 1 (EACH ML CONTAINS : MOXIFLOXACIN HYDROCHLORIDE USP 5.45MG EQUIV	$129.5K	8
MOFLOREN OPHTHALMIC SOLUTION 5ML PACK OF 1 EACH ML CONTAINS MOXIFLOXACIN HYDROCHLORIDE USP 5 45MG EQU	$37.0K	1
MOFLOREN OPHTHALMIC SOLUTION 5ML PACK OF 1 EACH ML CONTAINS MOXIFLOXACIN HYDROCHLORIDE USP 5 45MG EQUIVALENT TO MO	$21.5K	2
MO-FLOREN OP 5ML EACH ML CONTAINS MOXIFLOXACIN HYDROCHLORIDE 5.45 MG EQUIVALENTTO MOXIFLOXACIN USP(5.0 MG)	$17.5K	1
MOXIFLOXACIN OPTHALMIC SOLUTION USP 5 MG	$17.5K	1
MOFLOREN OPHTHALMIC SOLUTION 5ML, PACK OF - 1 EACH ML CONTAINS MOXIFLOXACIN HYDROCHLORIDE USP 5.45MG EQUIVALENT TO MO	$12.2K	2
. MOXIFLOXACIN OPHTHALMIC SOLUTION 0.5%5ML, PACK OF 1 EACH ML CONTAINS MOXIFLOXACIN HYDROCHLORIDE USP MOXIFLOXACIN 0.5NOS	$2.9K	1
MOFLOREN OPHTHALMIC SOLUTION 5ML, PACK OF - 1 (EACH ML CONTAINS : MOXIFLOXACIN HYCHLORIDE USP 5.45MG EQUIVALE	$933	1
MO-FLOREN OP 5ML (EACH ML CONTAINSMOXIFLOXACIN HYDROCHLORIDE 5.45 MG EQUIVALENT TO MOXIFLOXACIN USP(5.0 MG)	$724	1

Indoco Remedies Limited exports 9 distinct Moxifloxacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MOFLOREN OPHTHALMIC SOLUTION 5ML, PACK OF - 1 (EACH ML CONTA with 8 shipments worth $129.5K.

How Does Indoco Remedies Limited Compare to Nearest Moxifloxacin Exporters?

Exporters ranked immediately above and below #14 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
11	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$401.3K	15	6	$26.8K
13	HETERO LABS LIMITED	$260.9K	7	3	$37.3K
14	INDOCO REMEDIES LIMITED ★	$239.8K	18	8	$13.3K
15	ALVITA PHARMA PRIVATE LIMITED	$235.8K	8	1	$29.5K
12	AUROBINDO PHARMA LIMITED	$200.0K	4	1	$50.0K

Indoco Remedies Limited ranks #14 among 336 Indian Moxifloxacin exporters. Average shipment value of $13.3K compared to the market average of $42.4K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LIMITED and HETERO LABS LIMITED.

Which Indian Ports Ship Moxifloxacin Exports?

Port	Shipments	% Share
SAHAR AIR	311	12.9%
SAHAR AIR CARGO ACC (INBOM4)	263	10.9%
DELHI AIR CARGO ACC (INDEL4)	152	6.3%
DELHI AIR	132	5.5%
NHAVA SHEVA SEA (INNSA1)	126	5.2%
Bombay Air	119	4.9%
CHENNAI AIR	111	4.6%
CHENNAI AIR CARGO ACC (INMAA4)	93	3.9%

Geopolitical & Trade Policy Impact on Indoco Remedies Limited's Moxifloxacin Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Indoco Remedies. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased shipping costs and extended transit times. These maritime challenges are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and supply chain management. (pharmaceuticalcommerce.com)

Conversely, escalating US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of new tariffs by the US administration, with rates reaching up to 39% on imports from countries including India, poses a significant threat. These tariffs could affect approximately 55% of India's exports to the US, compelling companies like Indoco to reassess pricing strategies and explore new markets to mitigate potential revenue losses. (apnews.com)

In the European Union, stringent regulatory changes, such as the Falsified Medicines Directive, demand enhanced compliance measures from exporters. For Indoco, this necessitates investments in serialization and traceability technologies to ensure continued access to the EU market.

Indoco Remedies Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. Indoco Remedies has faced challenges in this arena; for instance, the company's Goa sterile facility was placed under Official Action Indicated status by the USFDA, indicating significant compliance issues. Such regulatory setbacks can impede market access and necessitate substantial remediation efforts. (alphastreet.com)

The broader Indian pharmaceutical industry has also encountered increased scrutiny, with the USFDA conducting over 200 inspections in 2023 and planning to escalate this number in 2024. This heightened oversight underscores the critical importance of stringent quality control and compliance measures for companies like Indoco to maintain and expand their export markets. (fact.net.in)

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Moxifloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Indoco Remedies Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 18 individual customs records matching Indoco Remedies Limited exporting Moxifloxacin, covering 9 formulations to 8 countries via 1 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 137+ countries, 731+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Moxifloxacin

Moxifloxacin

Indoco Remedies Limited — Moxifloxacin Exporter Profile

Indoco Remedies Limited — Moxifloxacin Export Profile: Buyers & Destinations

Where Does Indoco Remedies Limited Export Moxifloxacin?

Who Are the Top Buyers of Moxifloxacin from Indoco Remedies Limited?

What Is India's Total Moxifloxacin Export Value and How Much Does Indoco Remedies Limited Contribute?

What Is the Average Shipment Value for Indoco Remedies Limited's Moxifloxacin Exports?

How Does Indoco Remedies Limited Compare to Other Indian Moxifloxacin Exporters?

What Moxifloxacin Formulations Does Indoco Remedies Limited Export?

Regulatory Requirements: Exporting Moxifloxacin to Key Markets

South Africa — SAHPRA

How Does Indoco Remedies Limited Compare to Nearest Moxifloxacin Exporters?

Which Indian Ports Ship Moxifloxacin Exports?

Geopolitical & Trade Policy Impact on Indoco Remedies Limited's Moxifloxacin Exports

Indoco Remedies Limited — Regulatory Compliance & Quality Standards

About Indoco Remedies Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Moxifloxacin Export Data from Indoco Remedies Limited

Moxifloxacin Stats

Company Overview

Top Products by Indoco Remedies Limited

Related Analysis

Need Detailed Export Data?

Data Source